For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230308:nRSH3029Sa&default-theme=true
RNS Number : 3029S Solgenics Limited 08 March 2023
News Release
Confirmation of Change in Website Address
8 March 2023: Solgenics Limited ( the "Company") announces that, further to
its announcement on 2 March 2023, regarding the change of its name from
Ncondezi Energy Limited to Solgenics Limited, the Company's website address
has changed to www.solgenics.com (http://www.solgenics.com) with immediate
effect. The information required to be disclosed pursuant to AIM Rule 26 of
the AIM Rules for Companies can be accessed on
https://www.solgenics.com/aim-rule-26/
(https://www.solgenics.com/aim-rule-26/) .
In addition the Twitter handle has been updated to @solgenicsafrica
Enquiries
For further information please visit www.solgenics.com or contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566
Scott Mathieson, Edward Thomas, Kane Collings +44 (0) 20 3100 2000
Liberum Capital Limited:
NOMAD & Joint Broker
Novum Securities Limited Colin Rowbury +44 (0) 20 7399 9427
Joint Broker
Elizabeth Johnson +44 (0) 777 56 55 927
Pimlico Advisory Ltd
Investor Relations
About Solgenics
Solgenics (formerly Ncondezi Energy) is an African renewable energy
development company focused on the development of a 300MW solar PV plus BESS
renewable energy in the Tete Province in northern Mozambique (the "Tete Solar
Project").
It is the intention that the Tete Solar Project will connect to the Mozambique
grid with target power off takers
in Mozambique and the Southern African Power Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's leading
sustainable energy resources and is fully
aligned with Government's objective to become a champion for energy transition
impacting all Southern Africa.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUPUMWWUPWUBR